Ditchcarbon
  • Contact
  1. Organizations
  2. Allergan, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 3 months ago

Allergan, Inc. Sustainability Profile

Company website

Allergan, Inc., a prominent player in the global pharmaceutical industry, is headquartered in the United States. Founded in 1948, the company has established itself as a leader in medical aesthetics, eye care, and neuroscience, with significant operations across North America, Europe, and Asia. Allergan is renowned for its innovative products, including the iconic Botox, which revolutionised cosmetic treatments, and a diverse portfolio of therapeutic solutions. The company’s commitment to research and development has led to numerous breakthroughs, solidifying its market position as a trusted provider of advanced healthcare solutions. With a focus on enhancing patient outcomes, Allergan continues to achieve notable milestones, making it a key player in the ever-evolving pharmaceutical landscape.

DitchCarbon Score

How does Allergan, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

65

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Allergan, Inc.'s score of 65 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.

80%

Let us know if this data was useful to you

Allergan, Inc.'s reported carbon emissions

Inherited from AbbVie Inc.

Allergan, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years, as indicated by the absence of emissions figures. The company is a current subsidiary of AbbVie Inc., which means that any climate commitments or emissions data may be inherited from its parent organisation. Allergan's climate initiatives are aligned with those of AbbVie Inc., which has set various reduction targets and participates in industry-standard climate initiatives. However, specific reduction targets or achievements for Allergan itself have not been disclosed. The company is involved in initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are managed at the parent level. As a subsidiary, Allergan's climate commitments and performance metrics are likely influenced by AbbVie Inc.'s overarching sustainability strategies. This includes a focus on reducing Scope 1, 2, and 3 emissions, although specific figures for Allergan are not provided. In summary, while Allergan, Inc. does not present its own emissions data or specific reduction targets, it is part of a corporate family that is actively engaged in climate commitments through AbbVie Inc.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2015201620172018201920202021202220232024
Scope 1
402,448,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
-
-
-
-
-
-

How Carbon Intensive is Allergan, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Allergan, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Allergan, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Allergan, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Allergan, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Allergan, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Allergan, Inc.'s Emissions with Industry Peers

Alcon

CH
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 12 days ago

Cubist Pharmaceuticals LLC

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 months ago

Synthes Inc.

US
•
Health and social work services (85)
Updated 2 months ago

Fresenius Medical Care Holdings, Inc.

US
•
Health and social work services (85)
Updated 3 months ago

Jamjoom Pharmaceuticals Factory Company

SA
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Genentech

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251209.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy